Clarkston Capital Partners’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-18,379,976
Closed -$505M 185
2022
Q3
$505M Buy
18,379,976
+51,264
+0.3% +$1.27M 9.93% 1
2022
Q2
$423M Sell
18,328,712
-611,285
-3% -$14.3M 7.77% 1
2022
Q1
$413M Buy
18,939,997
+53,432
+0.3% +$1.11M 6.87% 2
2021
Q4
$404M Sell
18,886,565
-190,550
-1% -$4M 6.92% 2
2021
Q3
$399M Sell
19,077,115
-22,150
-0.1% -$483K 7.18% 2
2021
Q2
$440M Sell
19,099,265
-202,660
-1% -$4.66M 7.84% 2
2021
Q1
$427M Buy
19,301,925
+9,550
+0% +$221K 7.77% 2
2020
Q4
$360M Buy
19,292,375
+681,625
+4% +$11.2M 7.6% 2
2020
Q3
$270M Buy
18,610,750
+2,751,826
+17% +$35M 7.21% 2
2020
Q2
$178M Buy
15,858,924
+858,590
+6% +$9.64M 5.03% 6
2020
Q1
$150M Buy
15,000,334
+9,924,359
+196% +$139M 4.85% 6
2019
Q4
$83.2M Buy
5,075,975
+258,175
+5% +$3.46M 2.45% 14
2019
Q3
$58.2M Buy
+4,817,800
New +$66.2M 1.81% 20

Other funds holding CHNG

Clarkston Capital Partners's CHNG Position: Q4 2022 in Review

Clarkston Capital Partners sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 18,379,976 shares — an estimated $505M sold.

Clarkston Capital Partners first reported a position in CHNG in Q3 2019 and held it in 13 quarters. The position peaked at $505M in Q3 2022. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Clarkston Capital Partners reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Clarkston Capital Partners sold 18,379,976 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $505M.
  • Clarkston Capital Partners first reported a position in Change Healthcare Inc. Common Stock in Q3 2019 and held it in 13 quarters.
  • Clarkston Capital Partners's Change Healthcare Inc. Common Stock position peaked at $505M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Clarkston Capital Partners's 13F filing for Q4 2022, filed 13 Feb 2023.